The Trouble With Trump's Tariffs: Cramer's 'Mad Money' Recap
Trump's doubling down on trade issues. If you can't stand the pressure, then raise cash. Jim Cramer has your game plan for next week.
Replay: Jim Cramer on Bank Stocks, Cruise Stocks and Valeant Pharmaceuticals
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Wednesday's trending market topics from the floor of the New York Stock Exchange.
Jim Cramer: Barclays' $29 Price Target on Valeant Is 'Very Right'
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer thinks Barclay's $29 price target on Valeant Pharmaceuticals is "very right."
Royal Caribbean, Allergan, Tyson Foods: 'Mad Money' Lightning Round
Jim Cramer weighs in on Royal Caribbean, Allergan, Tyson Foods, Carrizo Oil & Gas, Valeant Pharmaceuticals, Okta, CRISPR Therapeutics and more.
Ceasefire in Trade War: Cramer's 'Mad Money' Recap
Jim Cramer says the hope that the trade dispute with China can be worked out was the fuel for this rally.
Billionaire Gautam Adani Loses $26 Billion in 3 Days
The Indian tycoon and his empire are facing allegations of fraud by an American short-seller. Their answer does not convince investors for the moment.
FTX: DOJ Seeks to Ban Bankman-Fried From Using Signal, Slack to Contact Employees
The Justice Department wants to ban Sam Bankman-Fried, the former CEO of bankrupt FTX, from speaking to former employees of the crypto exchange.
Elon Musk Has Questions About the War in Ukraine
The billionaire had proposed a controversial plan to end the Russia-Ukraine conflict, which now has lasted nearly a year.
A Royal Caribbean Cruise Line Adult Favorite Has Not Come Back
The cruise line has almost fully returned to normal after the covid pandemic, but one very popular activity hasn't been brought back.